Switzerland, together with the United Kingdom and Ireland, is one of three European countries which recognized Pharmaceutical Medicine as a medical specialty. This was the result of many efforts of the Swiss Society of Pharmaceutical Medicine (SSPM). Of note, the curriculum of students seeking to access this program is consistent with recommendations provided by a joint working group of professionals from the PharmaTrain Federation, IFAPP, and the Academy.
As science is rapidly evolving, and studies only a few years old may be entirely obsolete today, Pharmaceutical Medicine professionals must devote time and energy to Continuous Medical Education (CME). The requirements for CME vary from country to country, where some countries mandate CME and others deem it only vocational. In any case, more and more countries are considering the implementation of CME programs for all health care professionals, from those involved in direct patient care to those working in pharmaceutical companies and CROs.1
You can read the full manuscript here.
Disclaimers
- The material in these reviews is from various public open access sources, meant for educational and informational purposes only
- Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
- No official support by any organization(s) has been provided or should be inferred
References
- World Health Organization (23 April 2022). Disease Outbreak News; Multi-Country – Acute, severe hepatitis of unknown origin in children. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON376 Schnetzler, G. (2022, January 31). Evolution to a Competency-Based Training Curriculum for Pharmaceutical Medicine Physicians in Switzerland. Frontiers in Pharmacology. https://www.academia.edu/70125867/Evolution_to_a_Competency_Based_Training_Curriculum_for_Pharmaceutical_Medicine_Physicians_in_Switzerland?email_work_card=view-paper
